pifithrin has been researched along with Osteoporosis in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, F | 1 |
| Wang, Y | 2 |
| Wang, X | 2 |
| Wu, Y | 1 |
| Liu, Q | 1 |
| Zhu, Y | 1 |
| Liu, E | 1 |
| Fan, J | 1 |
1 other study available for pifithrin and Osteoporosis
| Article | Year |
|---|---|
Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53.
Topics: Animals; Benzothiazoles; Bone and Bones; Bone Marrow Cells; Cell Differentiation; Cyclin-Dependent K | 2017 |